Plasma apolipoprotein A1 as a biomarker for Parkinson disease (Q30544798)

18 August 2017

Plasma apolipoprotein A1 as a biomarker for Parkinson disease (English)

1 reference

18 August 2017

1 reference

0 references

14

1 reference

PubMed publication ID

24 June 2017

7

John Q Trojanowski

1 reference

18 August 2017

3

Andrew Siderowf

1 reference

18 August 2017

10

Thomas J Montine

1 reference

18 August 2017

Judy K Qiang

1

1 reference

18 August 2017

Yvette C Wong

2

1 reference

18 August 2017

Howard I Hurtig

4

1 reference

18 August 2017

Sharon X Xie

5

1 reference

18 August 2017

Virginia M-Y Lee

6

1 reference

18 August 2017

Dora Yearout

8

1 reference

18 August 2017

James B Leverenz

9

1 reference

18 August 2017

Matt Stern

11

1 reference

18 August 2017

Susan Mendick

12

1 reference

18 August 2017

Danna Jennings

13

1 reference

18 August 2017

Ken Marek

15

1 reference

18 August 2017

Alice S Chen-Plotkin

16

1 reference

18 August 2017

1 July 2013

1 reference

18 August 2017

1 reference

18 August 2017

74

1 reference

18 August 2017

1

1 reference

18 August 2017

119-127

1 reference

Prospective study of statin use and risk of Parkinson disease

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Pitavastatin: clinical effects from the LIVES Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

HDL-C: role as a risk modifier

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

The Parkinson Progression Marker Initiative (PPMI).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Preclinical biomarkers of Parkinson disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Physical activities and future risk of Parkinson disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Cognitive impairment and dementia in patients with Parkinson disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Is raising HDL a futile strategy for atheroprotection?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Association of olfactory dysfunction with risk for future Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Plasma urate and risk of Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Molecular markers of early Parkinson's disease based on gene expression in blood

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Imaging end points for monitoring neuroprotection in Parkinson's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Introduction to the plasma lipoproteins

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Ageing and Parkinson's disease: substantia nigra regional selectivity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

20 June 2018

1 reference

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan

21 January 2018

1 reference

High-Density Lipoprotein Therapy: Is There Hope?

21 January 2018

1 reference

Physical activity and the risk of Parkinson disease

21 January 2018

1 reference

Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression

21 January 2018

1 reference

Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease

21 January 2018

1 reference

Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis.

21 January 2018

1 reference

Apolipoprotein E genotype and Alzheimer's disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773265

Onset age of Parkinson disease

26 November 2018

1 reference

12 December 2020

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

1 reference

12 December 2020

Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease

1 reference

12 December 2020

Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport

1 reference

12 December 2020

Identifiers

DOI

10.1002/ANA.23872

1 reference

release_7dpp4ybq25hadd7p3pnvjvj2bm

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7dpp4ybq25hadd7p3pnvjvj2bm

24 November 2022

mapped directly with Wikidata item

1 reference

18 August 2017

PubMed publication ID

23447138

1 reference